Komori
Treasury Stock6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases and Completion of the Repurchase

The Company acquired 40,900 treasury shares through market purchases in November 2025, for an acquisition cost of ¥27,052,200. This completed the acquisition of treasury shares based on the resolution of the Board of Directors dated 14 May 2025.

Worth reading
72In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
40900
Shares
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Acquisition completedMarket purchases on the Tokyo Stock Exchange

Resolved 14 May 2025 / Acquisition period 2025年2月14日~2025年12月31日

100.0%
Cumulative utilization rate
Limit
Number of Shares300,000 shares (maximum)
86.8%
Cumulative utilization rate
LimitShares 100.0%
Amount2億50百万円(上限)
89.4%
経過
Deadline
Period2025年2月14日~2025年12月31日

The darker band is the portion acquired this time (2025年11月1日から2025年11月27日(約定ベース)). 株数の枠が先に埋まり、金額の上限は使い残しています。

Number of Shares
Limit300,000 shares (maximum)
Cumulative total300,000 株(2025年11月27日時点)
Current40,900 株
Amount
Limit2億50百万円(上限)
Cumulative total216,976,300 円(2025年11月27日時点)
Current27,052,200 円
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥661 per shareCurrent acquisition price ÷ current number of shares acquired
Whether acquisition has been completed

2025年11月27日をもって終了

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。 Elapsed time is counted against the acquisition period set in the resolution, as of 11/27/2025. 約定ベース=売買が成立した日を基準に数えた数字です。受け渡しの日ではありません。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction40,900 株
Total current acquisition price27,052,200 円
Acquisition date/acquisition period2025年11月1日から2025年11月27日(約定ベース)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired300,000 株(2025年11月27日時点)
Cumulative acquisition cost216,976,300 円(2025年11月27日時点)
Resolution date14 May 2025
Maximum number of shares to be acquired300,000 shares (maximum)
Total acquisition price2億50百万円(上限)
Acquisition period under the resolution2025年2月14日~2025年12月31日
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Whether acquisition has been completed2025年11月27日をもって終了
Items this document does not state (1)
Average Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

会社法第165条第3項により読み替えて適用される同法第156条の規定に基づく自己株式の取得を実施したため。取得終了の理由は明示されていない。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases and Completion of the Repurchase | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori